Inactive Instrument
Progenics Pharmaceuticals, Inc. Stock
Stocks
US7431871067
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
David Mims
CEO | Chief Executive Officer | 62 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/19/20 | Issuer sale | Director | 56,393 | 0.0651% | ||
| 6/19/20 | Issuer sale | Director | 170,000 | 0.1963% | ||
| 6/19/20 | Issuer sale | Executive/Senior Manager | 389,864 | 0.4502% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +1.49% | - | - | 355M | |
| +0.06% | +7.20% | +54.04% | +111.13% | 74.27B | |
| -2.29% | -2.68% | +32.41% | +75.07% | 61.21B | |
| +0.28% | +7.27% | +31.74% | +23.80% | 27.55B | |
| -2.05% | -1.32% | -18.40% | +352.20% | 26.38B | |
| -2.39% | +1.83% | -0.26% | -5.91% | 25.34B | |
| +0.57% | +6.60% | +26.25% | -9.37% | 20.84B | |
| -1.47% | +4.46% | -8.09% | +513.33% | 14.94B | |
| +1.29% | -2.49% | +163.31% | +333.06% | 15.17B | |
| -2.44% | -0.30% | +43.33% | +164.11% | 14.41B | |
| Average | -0.84% | +3.20% | +36.04% | +173.05% | 31.12B | |
| Weighted average by Cap. | -0.96% | +3.08% | +35.37% | +134.01% |
Employees
-
